You're reading the free version. Trader adds the live tape and alerts.
Start tracking
RGNX Sale Disclosure
Pakola Steve · SEC Form 4 · Filed Jul 6, 2026
Sale
Calculated transaction value
$29.48K
Pakola Steve Chief Medical Officer
RGNX
REGENXBIO Inc
RGNX
Transaction date
Jul 2, 2026
Public filing date
Jul 6, 2026
Filing lag
Filed 4 days later
RGNX daily price context
Close on/before transaction
$13.28
Jul 2, 2026
First close after public filing
$15.02
Jul 7, 2026
30-day return after filing
-30.09%
Through Aug 5, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 2,161 shares @ $13.64
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001700659-26-000014
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$46.46K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Regenxbio Inc. RGNX | Exercise | Jul 2, 2026 | $16.99K |
| Regenxbio Inc. RGNX Current | Sale | Jul 2, 2026 | $29.48K |
| Regenxbio Inc. RGNX | Exercise | Jul 2, 2026 | $0 |